Approval · Notice of Compliance 8628 · 2006
NEOSURF: Notice of Compliance 8628
Issued December 8, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8628
- Date
- December 8, 2006
- Company
- Cipla LtdMumbai,, Maharashtra, India
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Lung surfactant (bovine)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEOSURF | 02288621 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- PHOSPHOLIPID 27 MG per ML
- SURFACTANT-ASSOCIATED PROTEINS B & C 500 MCG per ML